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Human leukocyte antigen class II genetic variants
are highly associated with rheumatic heart disease
in Yemeni patients
Arwa Othman, Ahmed Al-motarreb, Masood HA 3
Background: Human leukocyte antigen (HLA) class II
polymorphisms have been reported as a risk factor for
rheumatic heart disease (RHD); however, the predisposing
HLA genetic variants were different in various populations.
The aim of the study: The aim of the study was to
investigate the association of RHD with HLA class II
alleles in Yemeni patients.
Methods: HLA-DRB1 and-DQB1 polymorphisms
were genotyped by PCR-SSOP reverse dot blot hybrid-
ization in 100 RHD patients and 50 healthy subjects with
normal echocardiography (control group).
Materials and methods: Subjects: Yemeni RHD
patients aged . . .14 and 45 years who attended the out-
patient clinic at Al-Thawra Hospital for treatment were
asked for participated in this study. One hundred RHD
patients (57 females, 43 males) were freely participated
(case group). Gender and age matched healthy subjects
aged—18 and 47 years in the same geographical area of
the patients were invited to participate in this study (con-
trol group). Fifty healthy individuals (28 females, 22
males) were freely participated. Venous blood, 3–4 ml
was collected from each participant after obtaining the
signed consent form. Echocardiogram was done for each
patient to confirm the clinical finding of RHD. The
healthy subjects were also subjected to echocardiograms
to exclude asymptomatic RHD cases.
HLA class II genotyping Genomic DNA was extracted
from peripheral blood leukocytes using PureLink Geno-
mic DNA kit (invitrogen, USA). HLA class II DRB1 and
DQB1 genotypes were carried out using sequence-spe-
cific oligonucleotide-probe polymerase chain reaction,
Dynal RELI SSOP HLA-DRB1 and HLA-DRB1 kits,
respectively (Invitrogen, USA).
Statistical analysis: Frequency of HLA-DRB1 and
HLA-DQB1 alleles were compared between the patients
and the controls using the chi-square test. The p value
and odds ratio (OR) were calculated using SPSS software,
version 12, with 95% confidence intervals and Fisher
exact correction for small numbers.
Results: The results showed that HLA-DRB1⁄07 and
HLA-DQB1⁄0203 allele were risk factors for RHD
(P = 0.005, OR = 4; P = 0.02, OR = 8.7, respectively). In con-
trast, the HLA-DRB1⁄11, HLA-DQB1⁄0305 and HLA-
DQB1⁄0602 alleles showed a protection against RHD
(P = 0.01, OR = 0.32; P = 0.03, OR = 0.23; P = 0.01,
OR = 0.24, respectively).
Conclusion: HLA class II genetic variants were a
predisposition factor for developing RHD in Yemeni sub-
jects. This study also replicated the association of HLA-
DRB1⁄07 with RHD and suggested that HLA-DQB1⁄0203
allele as a risk factor for RHD.
http://dx.doi:10.1016/j.jsha.2013.03.058
Gender differences in patients with out of hospital
cardiac arrest – A middle eastern perspective
Ashfaq Ahmad A.H. Patel, Abdulrahman Arabi,
R. Singh, Jassim Al Suwaidi
Objectives: To compare the clinical characteristics,
treatment and outcome in patients hospitalized following
out of Hospital Cardiac Arrest (OHCA) according to
gender.
Methods: Retrospective analysis of a registry of
patients hospitalized with OHCA over a 20-year period
(1991–2010) in Hamad Medical Corporation, Doha, Qatar.
Results: Out of 987 patients admitted with OHCA,
269 patients were female (27.3%). Compared to males,
females were older (61 + 14 vs 55 + 15 years; p = 0.001),
more likely to have diabetes (62.1% vs 35.5%; p = 0.001),
hypertension (63.9% vs 34.7%; p = 0.001), chronic renal
failure (12.3% vs 5.6%; p = 0.001) and BMI > 30 (41.2% vs
23.9%; p = 0.02) and less likely to be smokers (1.9% vs
26.6%; p = 0.001).
There was a lower incidence of STEMI in the female
patients (13.8% vs 36.1%; p = 0.001) with no significant
difference in the LV ejection fraction (35 ± 13 vs
34.5 ± 13; p = 0.81).
They were less likely to be treated with antithrombotic
medications (heparin/LMWH: 27.9% vs 35.9%; p = 0.02;
ASA: 47.2% vs 55.8%; p = 0.02; thrombolysis: 4.8% vs
17.3%; p = 0.001), PCI (5.2% vs 13%; p = 0.001) and IABP
support (0.7% vs 4.7%; p = 0.003).
In hospital mortality was higher in the female group
(65.4% vs 57.7%; p = 0.03).
Conclusion: There are significant differences in clin-
ical characteristics, treatment and outcome in patients
admitted with OHCA between male and female patients
in our database registry.
http://dx.doi:10.1016/j.jsha.2013.03.059
Diabetes, coronary artery disease and erectile dys-
function doppler study
Ayman Morsi, Bassam A. Faqih, Ahmed Alsaka
Objectives: To assess the role of measuring caverno-
sal artery blood flow as a screening tool for ischemic
heart disease in patients with erectile dysfunction (ED).
Methods: A total of 303 male patients with ED were
enrolled in this study. Patients were interviewed for ED
using the International Index of Erectile Function. The
penile vasculature was assessed using color Doppler
ultrasonography and the Digital Inflection Rigidometer.
All patients were referred to a cardiologist for evaluation
of ischemic heart disease (IHD). All patients underwent
routine laboratory investigations, plus total testosterone
and prolactin assessments.
Results: Seventy-six percent of the patients had
organic causes of ED. Of the 303 patients, 31.4% had
different degrees of IHD. A statistically significant
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